Skip to content

Sophie Delabie

Active Private limited companyfounded 2024active for 2 yearsBosveld 7, 2830 WillebroekKBO/BCE: BE 1004.744.707

Lifetime

2 annual accounts with figures on one time axis
peak of €85,143 in 2024
€81,878▼ 3.8%
peak of €52,925 in 2024
€48,799▼ 7.8%
peak of €103,724 in 2025
€103,724▲ 88.8%
€79,903▲ 129%
Board1 name since 2024
1 director
Documentsfilings and deeds
13-04-2026109 days before the deadline
2025micro format
Equity from €54,925 to €103,724Debts from €34,904 to €79,903Cash from €43,612 to €144,279

Key points

from the 2025 annual accounts

Turnover

≈ €240,000 estimated

The micro format states no turnover.

Position in the sector

€48,799

Higher net result than 81% of companies in pharmaceuticals. The sector median is €2,217, over 89 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Sophie Delabie has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Sophie Delabie. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 51 sharesdeed of 18-01-2024
  • 49 sharesdeed of 18-01-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1004744707
Incorporation Founding capital of €2,000, 100 shares · Founded by and · appointed as director · published on 18-01-2024 · Gazette deed
First establishment Bosveld 7, Willebroek
All 6 events

Comparable companies

same main activity, similar in size and age
Company
Sophie Delabie Willebroek €183,627 €81,878 56.5% -
BelCoPhar Kalmthout €224,468 €56,874 78.6% -
Scaldis Pharma Aalst €251,161 €54,532 2.3% -
BRUPHARM PHARMALAB Mons €298,430 €85,990 -34.5% -
Flindr Labs Ghent €262,929 €294,811 -148.7% 4.2
MAYAKU PHARMACEUTICAL DEVELOPMENT Ghent €170,483 €104,752 0.8% -
Dierenartsen Hond en Kat Deinze €321,318 €80,014 0.7% -

These companies have the same main activity as Sophie Delabie: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €170,000 and €321,000, founded between 2020 and 2024.

Official details

Source: KBO
Status
Active since 16-01-2024Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201and 5 others
Establishment unit
2.355.136.8382830 Willebroek, since 16-01-2024
Financial year end
31 December
Peppol
Reachable since 27-01-2026
Company details

Annual accounts 2025

€183,627▲ 104%
Filing
Filed on 13-04-2026, 109 days before the end of the filing period
Financials

Insights on Sophie Delabie

Sophie Delabie has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €103,724 and a net result of €48,799.

Its solvency ranks better than 59% of 89 sector peers (NACE 21) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Sophie Delabie

What is the company number of Sophie Delabie?
The company number of Sophie Delabie is 1004.744.707. The VAT number is the same number with BE in front: BE 1004.744.707.
Where is Sophie Delabie based?
The registered office is at Bosveld 7, 2830 Willebroek.Company details
What does Sophie Delabie do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
What is the legal form of Sophie Delabie?
Sophie Delabie is a private limited company (BV).
When was Sophie Delabie founded?
Sophie Delabie was founded on 16-01-2024.
Is Sophie Delabie still active?
Yes, Sophie Delabie is an active enterprise in the KBO register.
What is the turnover of Sophie Delabie?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €81,878 and 2,981 comparable companies of the same size. It probably lies between €160,000 and €420,000. It is a rough estimate.Financials
Is Sophie Delabie profitable?
In financial year 2025, Sophie Delabie made a profit of €48,799.
Where can I find the annual accounts of Sophie Delabie?
Sophie Delabie filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Sophie Delabie due?
Sophie Delabie must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.